MAM
NVO

Morse Asset Management’s Novo Nordisk NVO Stock Holding History

Morse Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,488
Closed -$892K – 362
2024
Q3 		$892K Sell
7,488
-20,148
-73% -$2.69M 0.19% 96
2024
Q2 		$3.94M Sell
27,636
-1,059
-4% -$140K 0.96% 34
2024
Q1 		$3.68M Buy
28,695
+4,390
+18% +$523K 0.94% 40
2023
Q4 		$2.51M Buy
24,305
+4,295
+21% +$425K 0.74% 44
2023
Q3 		$1.82M Buy
20,010
+1,564
+8% +$138K 0.58% 54
2023
Q2 		$1.49M Buy
18,446
+13,316
+260% +$1.09M 0.45% 60
2023
Q1 		$408K Buy
+5,130
New +$364K 0.14% 114

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Morse Asset Management's NVO Position: Q4 2024 in Review

Morse Asset Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 7,488 shares — an estimated $892K sold.

Morse Asset Management first reported a position in NVO in Q1 2023 and held it in 7 quarters. The position peaked at $3.94M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Morse Asset Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Morse Asset Management sold 7,488 Novo Nordisk shares in Q4 2024, an estimated $892K.
  • Morse Asset Management first reported a position in Novo Nordisk in Q1 2023 and held it in 7 quarters.
  • Morse Asset Management's Novo Nordisk position peaked at $3.94M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Morse Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.